THC Therapeutics terminates ST Holdings share exchange deal, citing accounting difficulty

THC Therapeutics, Inc.

Share Exchange Agreement with ST Holdings Group, LLC and its subsidiaries, signed June 20, 2025, was terminated by mutual agreement on October 30, 2026.
Company cited difficulty accounting for the transaction; the parties are still discussing a possible future acquisition of some or all ST Holdings assets.
On July 7, 2026 the company filed a Nevada Amended and Restated Certificate of Designation creating 500,000 Series D Convertible Preferred shares.
Each Series D share carries 10 votes, converts into common at $0.01 per share, and participates with common stock in any declared dividends.
Filing signed by Scott Cox, Interim Chief Executive Officer, and dated October 30, 2026.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.